We are live on ! Find out more
SMC

S. Muoio & Co Portfolio holdings

AUM $75.7M
1-Year Est. Return 42.51%
This Fund
S&P 500
This Quarter Est. Return
+16.77%
1 Year Est. Return
+42.51%
3 Year Est. Return
+327.42%
5 Year Est. Return
+691.71%
10 Year Est. Return
–
AUM
$111M
AUM Growth
+$15.9M
Cap. Flow
-$7.18M
Cap. Flow %
-6.45%
Top 10 Hldgs %
47.05%
Holding
91
New
16
Increased
10
Reduced
12
Closed
20

Top Buys

Rank Stock Value
1
PARA
Paramount Global Class B
PARA
+$3.56M
2
AGN
Allergan plc
AGN
+$2.16M
3
BOLD
Audentes Therapeutics, Inc
BOLD
+$2.14M
4
WBC
WABCO HOLDINGS INC.
WBC
+$2.02M
5
GBL
GAMCO Investors, Inc.
GBL
+$1.41M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$7.92M
2
CBM
Cambrex Corporation
CBM
+$2.99M
3
VIAB
Viacom Inc. Class B
VIAB
+$2.84M
4
GWR
Genesee & Wyoming Inc.
GWR
+$2.23M
5
MCRN
Milacron Holdings Corp.
MCRN
+$1.27M

Sector Composition

Rank Sector Weight
1 Communication Services 30.44%
2 Miscellaneous 15%
3 Healthcare 13.38%
4 Consumer Discretionary 13.26%
5 Technology 10.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GWR
76
DELISTED
Genesee & Wyoming Inc.
GWR
– –
-20,000
Closed -$2.23M
PVTL
77
DELISTED
Pivotal Software, Inc.
PVTL
– –
-30,000
Closed -$450K
CRZO
78
DELISTED
Carrizo Oil & Gas Inc
CRZO
– –
-150,000
Closed -$1.1M
PSDO
79
DELISTED
Presidio, Inc. Common Stock
PSDO
– –
-50,000
Closed -$829K
ONCE
80
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
– –
-7,000
Closed -$769K
VSI
81
DELISTED
Vitamin Shoppe Inc.
VSI
– –
-115,800
Closed -$752K
FCSC
82
DELISTED
Fibrocell Science Inc.
FCSC
– –
-11,590
Closed -$35K
CBM
83
DELISTED
Cambrex Corporation
CBM
– –
-50,000
Closed -$2.99M
VIAB
84
DELISTED
Viacom Inc. Class B
VIAB
– –
-129,101
Closed -$2.84M
AVDR
85
DELISTED
Avedro, Inc Common Stock
AVDR
– –
-30,000
Closed -$716K
MCRN
86
DELISTED
Milacron Holdings Corp.
MCRN
– –
-75,000
Closed -$1.27M
PNTR
87
DELISTED
Pointer Telocation Ltd.
PNTR
– –
-54,160
Closed -$827K
NYNY
88
DELISTED
Empire Resorts, Inc.
NYNY
– –
-19,256
Closed -$188K
VIA
89
DELISTED
Viacom Inc. Class A
VIA
– –
-19,525
Closed -$480K
CELG
90
DELISTED
Celgene Corp
CELG
– –
-73,000
Closed -$7.92M
GCI
91
DELISTED
Gannett Co., Inc
GCI
– –
-90,158
Closed -$968K
1 2 3
4

Similar funds

FFMBT
First Farmers & Merchants Bank Trust Columbia, Tennessee $75.4M AUM 6.56% 1-Year Est. Return
NVPX
Norwest Venture Partners XII Palo Alto, California $75.4M AUM 53.35% 1-Year Est. Return
WM
Westpark Management Plano, Texas $75.3M AUM 22.07% 1-Year Est. Return
RA
Ratos AB Stockholm, Sweden $76.4M AUM
RC
Ronit Capital London, United Kingdom $74.3M AUM 13.35% 1-Year Est. Return
GI
Gavea Investimentos Rj, Brazil $77.6M AUM 64.56% 1-Year Est. Return
PM
Ponoi Management San Francisco, California $73.2M AUM 23.44% 1-Year Est. Return
PIMH
Prudence Investment Management (HK) 12 Harcourt Road Central, Hong Kong $78.2M AUM 52.44% 1-Year Est. Return

S. Muoio & Co's Q4 2019 Portfolio in Review

As of Q4 2019, S. Muoio & Co held 91 positions worth $111M, up 17% from $95.3M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

S. Muoio & Co withdrew a net $7.18M in Q4 2019, closing 20 positions and reducing 12 holdings. Its most notable exit was Celgene Corp, an estimated $7.92M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 30% of assets, down from 33% a quarter earlier, followed by Miscellaneous and Healthcare.

Against the trend, S. Muoio & Co opened a new position in Audentes Therapeutics, Inc worth $3.41M.

  • S. Muoio & Co's largest Q4 2019 buy was Audentes Therapeutics, Inc: 57,000 shares worth $3.41M.
  • S. Muoio & Co added most to Paramount Global Class B in Q4 2019, an estimated $3.56M increase.
  • S. Muoio & Co's biggest Q4 2019 reduction was Phibro Animal Health, cutting an estimated $1.02M.
  • S. Muoio & Co fully exited Celgene Corp in Q4 2019, selling an estimated $7.92M.
  • S. Muoio & Co's ten largest holdings make up 47% of its $111M portfolio in Q4 2019.
  • S. Muoio & Co opened 16 new positions and closed 20 in Q4 2019.
  • S. Muoio & Co's portfolio value rose 17% quarter-over-quarter to $111M.

Based on S. Muoio & Co's 13F filing for Q4 2019, filed 12 Feb 2020.